Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology

Bilici, Ahmet; Ozturk, Turkan; Turkmen, Esma; Odabas, Hatice; Cihan, Sener; Selcukbiricik, Fatih; ERDOĞAN, BÜLENT; Urakci, Zurat; Kandemir, Nurten; Bayoglu, Ibrahim; Demirci, Umut; Duran, Ayse; Sendur, Mehmet; Yavuzer, Dilek; HARPUTLUOĞLU, HAKAN; Kavgaci, Halil; Gumus, Mahmut

doi:10.1007/s00345-015-1492-9

Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology

Atıf İçin Kopyala

Bilici A., Ozturk T., Turkmen E., Odabas H., Cihan S., Selcukbiricik F., ...Daha Fazla

WORLD JOURNAL OF UROLOGY, cilt.33, sa.10, ss.1613-1622, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 33 Sayı: 10
Basım Tarihi: 2015
Doi Numarası: 10.1007/s00345-015-1492-9
Dergi Adı: WORLD JOURNAL OF UROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1613-1622
İnönü Üniversitesi Adresli: Evet

Özet

Approximately 75 % of patients with testicular seminoma present with stage I disease, and the probability of long-term survival approaches 100 %. However, the standard adjuvant treatment for stage I seminoma patients remains controversial, and there is no uniform consensus in the literature. The present study was performed to evaluate treatment preference and outcomes for men with stage I testicular seminoma.